Ledger.Open graph →
SEC Form D · filed May 12, 2021

SignPath Pharma, Inc

Offering
$11.0M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Sandy, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Peter P. Sordillo · Sandy, UTExecKai Larson · Sandy, UTExec · DirectorRobert P. Seguso · Sandy, UTExec · DirectorJeffrey Rosengarten · Northbrook, ILExec · DirectorKenneth S. Kranzberg · New York, NYExec · DirectorArash Soheili · Kensington, MDExecArthur Ballon, Ph.D · Sandy, UTExec · DirectorTimothy Touloukian · Sandy, UTExecLouis Laskis · TEMPE, AZExec · DirectorShawn R. Jenkins · CHARLESTON, SCExec · DirectorDonald R. Taylor · CHARLESTON, SCExecArthur Ballon, Ph.D · Sandy, UTExec · DirectorTimothy Touloukian · Sandy, UTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗